Regeneron Pharmaceuticals Inc recalls
Every recall we track for Regeneron Pharmaceuticals Inc — 3 in all, from 2024–2026 — plus the complaints and injury reports the public filed about them. 3 are rated “stop using now”.
Recalls per year, by danger level
3 recalls since 2017.
All FDA recall records for Regeneron Pharmaceuticals Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 2 | 0 | 0 | 0 | 2 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 1 | 0 | 0 | 0 | 1 |
Most common reasons for Regeneron Pharmaceuticals Inc recalls
What to do if you have a recalled Regeneron Pharmaceuticals Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Regeneron Pharmaceuticals Inc recalls
3 shown- Stop using nowDrug
Regeneron Pharmaceuticals Inc recalls Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial,
Regeneron recalls Libtayo (cemiplimab-rwlc) injections due to lack of sterility assurance. This could lead to infections if used improperly. Affected units have specific lot numbers and expiration dates.
RegeneronJul 28, 2026 - Stop using nowDrug
Regeneron Pharmaceuticals Inc recalls EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled
Regeneron recalls 405,725 EYLEA prefilled syringes due to lack of sterility assurance and syringe breakage complaints. Check lot numbers immediately.
RegeneronMay 15, 2024 - Stop using nowDrug
Regeneron Pharmaceuticals Inc recalls EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only,
Regeneron recalls specific lots of EYLEA single-dose pre-filled syringes due to lack of sterility assurance and syringe breakage complaints.
RegeneronApr 23, 2024
Regeneron Pharmaceuticals Inc recall questions
How many recalls has Regeneron Pharmaceuticals Inc had?
3 recalls from Regeneron Pharmaceuticals Inc are on record with U.S. safety agencies, from 2024–2026.
What is the most recent Regeneron Pharmaceuticals Inc recall?
Regeneron Pharmaceuticals Inc recalls Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial,, dated Jul 28, 2026. Every Regeneron Pharmaceuticals Inc recall is listed on this page, newest first.
Why are Regeneron Pharmaceuticals Inc products recalled?
The most common reasons on record: Lack of Assurance of Sterility: Complaints of syringe breakage (2).
What should I do if I have a recalled Regeneron Pharmaceuticals Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Regeneron Pharmaceuticals Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.